A detailed history of Emerald Mutual Fund Advisers Trust transactions in Insmed Inc stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 487,664 shares of INSM stock, worth $34.4 Million. This represents 2.01% of its overall portfolio holdings.

Number of Shares
487,664
Previous 493,849 1.25%
Holding current value
$34.4 Million
Previous $33.1 Million 7.59%
% of portfolio
2.01%
Previous 1.88%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$62.0 - $79.01 $383,470 - $488,676
-6,185 Reduced 1.25%
487,664 $35.6 Million
Q2 2024

Aug 06, 2024

BUY
$22.0 - $69.71 $200,970 - $636,800
9,135 Added 1.88%
493,849 $33.1 Million
Q1 2024

May 08, 2024

SELL
$25.72 - $29.94 $6.78 Million - $7.89 Million
-263,630 Reduced 35.23%
484,714 $13.2 Million
Q4 2023

Feb 05, 2024

BUY
$23.42 - $31.74 $84,569 - $114,613
3,611 Added 0.48%
748,344 $23.2 Million
Q3 2023

Oct 26, 2023

SELL
$19.86 - $26.93 $1.8 Million - $2.44 Million
-90,563 Reduced 10.84%
744,733 $18.8 Million
Q2 2023

Aug 10, 2023

SELL
$16.44 - $21.1 $5,392 - $6,920
-328 Reduced 0.04%
835,296 $17.6 Million
Q1 2023

May 04, 2023

BUY
$16.26 - $21.73 $1.44 Million - $1.92 Million
88,478 Added 11.84%
835,624 $14.2 Million
Q4 2022

Feb 03, 2023

BUY
$16.98 - $23.15 $12.7 Million - $17.3 Million
747,146 New
747,146 $14.9 Million
Q1 2020

Apr 30, 2020

SELL
$13.63 - $33.98 $8.41 Million - $21 Million
-617,373 Closed
0 $0
Q4 2019

Jan 29, 2020

SELL
$16.12 - $24.98 $4.75 Million - $7.36 Million
-294,563 Reduced 32.3%
617,373 $14.7 Million
Q3 2019

Oct 31, 2019

BUY
$15.49 - $25.78 $1.08 Million - $1.8 Million
69,690 Added 8.27%
911,936 $16.1 Million
Q2 2019

Jul 31, 2019

BUY
$23.0 - $32.19 $25,921 - $36,278
1,127 Added 0.13%
842,246 $21.6 Million
Q1 2019

May 01, 2019

BUY
$13.91 - $31.15 $4.57 Million - $10.2 Million
328,472 Added 64.07%
841,119 $24.5 Million
Q4 2018

Jan 31, 2019

SELL
$11.6 - $18.7 $3.87 Million - $6.23 Million
-333,211 Reduced 39.39%
512,647 $6.73 Million
Q3 2018

Oct 31, 2018

BUY
$18.95 - $28.08 $4.09 Million - $6.06 Million
215,743 Added 34.24%
845,858 $17.1 Million
Q2 2018

Jul 31, 2018

BUY
$20.0 - $29.72 $26,720 - $39,705
1,336 Added 0.21%
630,115 $14.9 Million
Q1 2018

Apr 26, 2018

SELL
$21.69 - $32.99 $1.49 Million - $2.26 Million
-68,553 Reduced 9.83%
628,779 $14.2 Million
Q4 2017

Feb 06, 2018

BUY
$26.43 - $31.78 $104,927 - $126,166
3,970 Added 0.57%
697,332 $21.7 Million
Q3 2017

Oct 30, 2017

BUY
$11.61 - $31.21 $8.05 Million - $21.6 Million
693,362
693,362 $21.6 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.54B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Emerald Mutual Fund Advisers Trust Portfolio

Follow Emerald Mutual Fund Advisers Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.